| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2020 | MacHiels Alec57 | Director | Sale+OE | 7,500 | $35.00 | $262,500.00 | -1.1% | |
| Oct 7, 2020 | Brown Victoria L. | Program Team Lead | Sale+OE | 12,000 | $35.00 | $420,000.00 | -76.9% | |
| Oct 1, 2020 | Grossi Federico53 | See Remarks | Sell | 600 | $30.22 | $18,132.00 | -2.1% | |
| Sep 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $30.96 | $154,800.00 | -0.5% | |
| Sep 1, 2020 | Grossi Federico53 | See Remarks | Sell | 600 | $31.58 | $18,948.00 | -2.0% | |
| Aug 20, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 3,457 | $30.00 | $103,710.00 | -0.3% | |
| Aug 18, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 1,543 | $30.00 | $46,290.00 | -0.1% | |
| Aug 3, 2020 | Grossi Federico53 | See Remarks | Sell | 600 | $26.28 | $15,768.00 | -2.0% | |
| Jul 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $32.12 | $160,600.00 | -0.5% | |
| Jul 1, 2020 | Grossi Federico53 | See Remarks | Sell | 850 | $32.43 | $27,565.50 | -2.7% |